These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9480138

  • 1. [Enzyme immunoassay for the determination of serotonin in stored platelet concentrates].
    Ganschow I, Benn HP, Fischer R, Cassens U, Dittmer R, Kühnl P.
    Beitr Infusionsther Transfusionsmed; 1994; 32():428-30. PubMed ID: 9480138
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A, Kurtz J, Moroff G, Wagner SJ.
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [Abstract] [Full Text] [Related]

  • 4. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E, Figueiredo AC, Seghatchian J.
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [Abstract] [Full Text] [Related]

  • 5. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L, Taaning E, Dreier B, Christensen LD, Mynster T, Nielsen HJ.
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [Abstract] [Full Text] [Related]

  • 6. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R, Fröhlich A, Mayaudon V, Lin L.
    J Clin Apher; 2004 Jul; 19(4):185-91. PubMed ID: 15597347
    [Abstract] [Full Text] [Related]

  • 7. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
    Cardigan R, Sutherland J, Garwood M, Bashir S, Turner C, Smith K, Hancock V, Wiltshire M, Pergande C, Williamson LM.
    Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of thrombocyte concentrates from buffy coats after 3 and 16 hours of storage].
    Häberle H, Schulzki T, Kretschmer V.
    Beitr Infusionsther Transfusionsmed; 1994 Feb; 32():73-7. PubMed ID: 9480161
    [Abstract] [Full Text] [Related]

  • 9. Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
    Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J.
    Transfusion; 2008 Apr; 48(4):723-30. PubMed ID: 18208415
    [Abstract] [Full Text] [Related]

  • 10. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates.
    Mohr H, Bayer A, Gravemann U, Müller TH.
    Transfusion; 2006 Jun; 46(6):949-55. PubMed ID: 16734811
    [Abstract] [Full Text] [Related]

  • 11. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
    Tynngård N, Lindahl TL, Trinks M, Studer M, Berlin G.
    Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
    [Abstract] [Full Text] [Related]

  • 12. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system.
    Larsson S, Sandgren P, Sjödin A, Vesterinen M, Gulliksson H.
    Transfusion; 2005 May; 45(5):743-51. PubMed ID: 15847664
    [Abstract] [Full Text] [Related]

  • 13. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
    Sandgren P, Hansson M, Gulliksson H, Shanwell A.
    Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
    [Abstract] [Full Text] [Related]

  • 14. [Relationship of state of aggregation with various biochemical parameters--tested on platelet concentrates from buffy coats after 5 days of storage].
    Posch U, Kokelj M, Kostner GM, Lanzer G.
    Beitr Infusionsther Transfusionsmed; 1994 Jul; 32():78-80. PubMed ID: 9480162
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
    Vetlesen A, Mirlashari MR, Ezligini F, Kjeldsen-Kragh J.
    Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
    [Abstract] [Full Text] [Related]

  • 16. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J.
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [Abstract] [Full Text] [Related]

  • 17. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G.
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the Impact-R for monitoring the platelet storage lesion.
    Albanyan AM, Murphy MF, Harrison P.
    Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
    [Abstract] [Full Text] [Related]

  • 19. [Changes in platelet concentrates from dogs due to storage. I. Platelet count in in vitro function].
    Klein A, Adamik A, Mischke R.
    Berl Munch Tierarztl Wochenschr; 1999 Feb; 112(6-7):243-53. PubMed ID: 10472723
    [Abstract] [Full Text] [Related]

  • 20. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage.
    Glenister KM, Payne KA, Sparrow RL.
    Transfusion; 2008 Jan; 48(1):99-107. PubMed ID: 17894789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.